{"id":46727,"date":"2022-07-29T13:01:58","date_gmt":"2022-07-29T11:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/"},"modified":"2022-07-29T13:01:58","modified_gmt":"2022-07-29T11:01:58","slug":"concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/","title":{"rendered":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022"},"content":{"rendered":"
\n

\nNew Online Registration Required for Live Call to Ask Questions<\/i><\/b>\n<\/p>\n

\nAudio-Only Webcast Still Available on Concert\u2019s Website<\/i><\/b>\n<\/p>\n

LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE<\/a> #AlopeciaAreata<\/a>—Concert Pharmaceuticals, Inc.<\/a> (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2022, on Thursday, August 4, 2022, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss its second quarter 2022 financial results and provide a business update.\n<\/p>\n

<\/a><\/p>\n

\nPlease note that there is a new system to access the live call in order to ask questions. To join the live call, please register here.<\/a> A dial in and unique PIN will be provided to join the call.\n<\/p>\n

\nAn audio-only webcast of the call may be accessed in the Investors<\/a> section of the Company\u2019s website at www.concertpharma.com<\/a>. A replay of the webcast will be available on Concert\u2019s website for three months.\n<\/p>\n

\nAbout Concert<\/b>\n<\/p>\n

\nConcert Pharmaceuticals<\/a> is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform\u00ae<\/sup><\/a> (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert\u2019s lead product candidate<\/a> is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com<\/a> or follow us on Twitter at @ConcertPharma<\/a> or on LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor additional information contact:<\/b>
Justine Koenigsberg
\n
(781) 674-5284
\n
ir@concertpharma.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

New Online Registration Required for Live Call to Ask Questions Audio-Only Webcast Still Available on Concert\u2019s Website LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2022, on Thursday, August 4, 2022, before the U.S. financial markets open. The Company will host … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46727","6":"format-standard","7":"category-industry"},"yoast_head":"\nConcert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"New Online Registration Required for Live Call to Ask Questions Audio-Only Webcast Still Available on Concert\u2019s Website LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2022, on Thursday, August 4, 2022, before the U.S. financial markets open. The Company will host ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-29T11:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022\",\"datePublished\":\"2022-07-29T11:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/\"},\"wordCount\":282,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220729005197\\\/en\\\/407268\\\/21\\\/concert_logo_r_1976x566.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/\",\"name\":\"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220729005197\\\/en\\\/407268\\\/21\\\/concert_logo_r_1976x566.jpg\",\"datePublished\":\"2022-07-29T11:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220729005197\\\/en\\\/407268\\\/21\\\/concert_logo_r_1976x566.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220729005197\\\/en\\\/407268\\\/21\\\/concert_logo_r_1976x566.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend","og_description":"New Online Registration Required for Live Call to Ask Questions Audio-Only Webcast Still Available on Concert\u2019s Website LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #AlopeciaAreata—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the second quarter of 2022, on Thursday, August 4, 2022, before the U.S. financial markets open. The Company will host ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-29T11:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022","datePublished":"2022-07-29T11:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/"},"wordCount":282,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/","url":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/","name":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg","datePublished":"2022-07-29T11:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220729005197\/en\/407268\/21\/concert_logo_r_1976x566.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/concert-pharmaceuticals-to-report-second-quarter-2022-results-on-august-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Concert Pharmaceuticals to Report Second Quarter 2022 Results on August 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46727"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46727\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}